<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02387021</url>
  </required_header>
  <id_info>
    <org_study_id>P-2015002/AR</org_study_id>
    <nct_id>NCT02387021</nct_id>
  </id_info>
  <brief_title>Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia</brief_title>
  <official_title>Prospective Comparison Between Continuous Femoral Nerve Block and the Association of Adductor Canal Block and Sciatic Nerve Block in Total Knee Arthroplasty.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Kassab d'Orthopédie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Kassab d'Orthopédie</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether the association of sciatic nerve block to
      continuous adductor canal block is effective in the treatment of total knee arthroplasty post
      operative pain .
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Opioid-consumption</measure>
    <time_frame>8 hours postoperative</time_frame>
    <description>Cumulative opioid consumption : converting oral, intravenous, and patient-controlled analgesia PCA opioid to morphine equivalent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NRS pain score at rest</measure>
    <time_frame>0,1,2,4,6,8,12,24 and 48 hours postoperative</time_frame>
    <description>NRS pain scores determined by patient interview, using the standard NRS of 0 to 10 scale at rest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS pain score during movement</measure>
    <time_frame>0,1,2,4,6,8,12,24 and 48 hours postoperative</time_frame>
    <description>NRS pain scores determined by patient interview, using the standard NRS of 0 to 10 scale, during physiotherapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS pain score after 10 meters of walk or maximum walked distance</measure>
    <time_frame>8, 24 and 48 hours postoperative</time_frame>
    <description>NRS pain scores determined by patient interview, using the standard NRS of 0 to 10 scale after 10 meters walk (if enable after maximum walked distance).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to walk</measure>
    <time_frame>8, 24 and 48 hours postoperative</time_frame>
    <description>The ability of the patient to stand up and walk 3 meters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TUG Test</measure>
    <time_frame>8, 24 and 48 hours postoperative</time_frame>
    <description>The TUG test measures the time it takes a patient to stand up from a chair, walk a distance of 3 m, and return to the chair</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The 10-m walk test</measure>
    <time_frame>8, 24 and 48 hours postoperative</time_frame>
    <description>time it takes the patient to walk a distance of 10 m as quickly as possible</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>8, 24 and 48 hours postoperative</time_frame>
    <description>patient interviewed, using a scale of 0-10, 0 not satisfied and 10 being the most satisfied</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <condition>Pain Management</condition>
  <arm_group>
    <arm_group_label>Continous femoral nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive ultrasound-guided (USG) continuous femoral nerve block with 20 ml ropivacaine 0.2% and USG Continuous adductor canal block with 20 ml of saline and USG infragluteal SNB with 20 ml of saline .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous adductor canal block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive ultrasound-guided continuous adductor canal block with 20 ml ropivacaine 0.2% and USG infragluteal SNB with 20 ml ropivacaine 0.2% and USG continuous FNB with 20 ml of saline .</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous femoral nerve block</intervention_name>
    <arm_group_label>Continous femoral nerve block</arm_group_label>
    <arm_group_label>Continuous adductor canal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous adductor canal block</intervention_name>
    <arm_group_label>Continous femoral nerve block</arm_group_label>
    <arm_group_label>Continuous adductor canal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>infragluteal Sciatic nerve block</intervention_name>
    <arm_group_label>Continous femoral nerve block</arm_group_label>
    <arm_group_label>Continuous adductor canal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.2%</intervention_name>
    <arm_group_label>Continous femoral nerve block</arm_group_label>
    <arm_group_label>Continuous adductor canal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <arm_group_label>Continous femoral nerve block</arm_group_label>
    <arm_group_label>Continuous adductor canal block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective unilateral TKA,

          -  Planned continuous spinal anesthesia ,

          -  Ability to follow study protocol,

          -  American Society of Anesthesiologists class 1 to 3.

        Exclusion Criteria:

          -  Contraindication for neuraxial anesthetic,

          -  Chronic opioid use (defined as daily or almost daily use of opioids for &gt;3 months),

          -  Hypersensitivity and/or allergies to any of the study medications,

          -  Intraoperative use of volatile anesthetics,

          -  Preexisting neuropathy on the operative limb,

          -  Contraindications to a femoral, adductor canal or Tibial nerve block.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karim Raies, M.D</last_name>
    <phone>+21655208602</phone>
    <email>karim.raies@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Kim DH, Lin Y, Goytizolo EA, Kahn RL, Maalouf DB, Manohar A, Patt ML, Goon AK, Lee YY, Ma Y, Yadeau JT. Adductor canal block versus femoral nerve block for total knee arthroplasty: a prospective, randomized, controlled trial. Anesthesiology. 2014 Mar;120(3):540-50. doi: 10.1097/ALN.0000000000000119.</citation>
    <PMID>24401769</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2015</study_first_posted>
  <last_update_submitted>March 7, 2015</last_update_submitted>
  <last_update_submitted_qc>March 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut Kassab d'Orthopédie</investigator_affiliation>
    <investigator_full_name>Rais Karim</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>nerve block</keyword>
  <keyword>Total knee replacement</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

